- Home
- JOB vs CRIS Comparison
JOB vs CRIS Comparison
Compare JOB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- CRIS
- Stock Information
- Founded
- JOB 1893
- CRIS 2000
- Country
- JOB United States
- CRIS United States
- Employees
- JOB N/A
- CRIS N/A
- Industry
- JOB Diversified Commercial Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JOB Consumer Discretionary
- CRIS Health Care
- Exchange
- JOB Nasdaq
- CRIS Nasdaq
- Market Cap
- JOB 22.5M
- CRIS 22.9M
- IPO Year
- JOB N/A
- CRIS 2000
- Fundamental
- Price
- JOB $0.20
- CRIS $1.49
- Analyst Decision
- JOB
- CRIS Strong Buy
- Analyst Count
- JOB 0
- CRIS 2
- Target Price
- JOB N/A
- CRIS $16.50
- AVG Volume (30 Days)
- JOB 223.8K
- CRIS 76.4K
- Earning Date
- JOB 12-18-2025
- CRIS 11-13-2025
- Dividend Yield
- JOB N/A
- CRIS N/A
- EPS Growth
- JOB N/A
- CRIS N/A
- EPS
- JOB N/A
- CRIS N/A
- Revenue
- JOB $108,752,000.00
- CRIS $11,405,000.00
- Revenue This Year
- JOB $43.94
- CRIS $2.72
- Revenue Next Year
- JOB N/A
- CRIS $8.27
- P/E Ratio
- JOB N/A
- CRIS N/A
- Revenue Growth
- JOB N/A
- CRIS 12.24
- 52 Week Low
- JOB $0.17
- CRIS $1.02
- 52 Week High
- JOB $0.51
- CRIS $5.05
- Technical
- Relative Strength Index (RSI)
- JOB 45.34
- CRIS 40.27
- Support Level
- JOB $0.19
- CRIS $1.48
- Resistance Level
- JOB $0.21
- CRIS $1.68
- Average True Range (ATR)
- JOB 0.01
- CRIS 0.10
- MACD
- JOB -0.00
- CRIS -0.00
- Stochastic Oscillator
- JOB 53.82
- CRIS 19.83
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.